149 related articles for article (PubMed ID: 17309394)
1. Impact of meningococcal C conjugate vaccine use in Australia.
Booy R; Jelfs J; El Bashir H; Nissen MD
Med J Aust; 2007 Feb; 186(3):108-9. PubMed ID: 17309394
[No Abstract] [Full Text] [Related]
2. Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
Pollard AJ; Green C; Sadarangani M; Snape MD
Arch Dis Child; 2013 Apr; 98(4):248-51. PubMed ID: 23482919
[No Abstract] [Full Text] [Related]
3. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme.
Lawrence GL; Wang H; Lahra M; Booy R; McINTYRE PB
Epidemiol Infect; 2016 Aug; 144(11):2382-91. PubMed ID: 27094814
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
6. Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end.
Lansley M; Bedford H
Vaccine; 2003 Jun; 21(21-22):2877-81. PubMed ID: 12798630
[TBL] [Abstract][Full Text] [Related]
7. Immunisation update: Meningococcal B and ACWY vaccines.
Davidson GT; Heaton PA; Paul SP
J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934
[No Abstract] [Full Text] [Related]
8. Estimating the burden of serogroup C meningococcal disease in England and Wales.
Davison KL; Ramsay ME; Crowcroft NS; Lieftucht A; Kaczmarski EB; Trotter CL; Gungabissoon U; Begg NT
Commun Dis Public Health; 2002 Sep; 5(3):213-9. PubMed ID: 12434691
[TBL] [Abstract][Full Text] [Related]
9. Perils of launching a new vaccination campaign.
Dobson F
BMJ; 2014 Apr; 348():g2449. PubMed ID: 24699385
[No Abstract] [Full Text] [Related]
10. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
11. Cross sectional survey of meningococcal C immunisation in children looked after by local authorities and those living at home.
Hill CM; Mather M; Goddard J
BMJ; 2003 Feb; 326(7385):364-5. PubMed ID: 12586668
[No Abstract] [Full Text] [Related]
12. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
Pace D; Pollard AJ
Arch Dis Child; 2007 Oct; 92(10):909-15. PubMed ID: 17895339
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.
De Wals P; Deceuninck G; Boulianne N; De Serres G
JAMA; 2004 Nov; 292(20):2491-4. PubMed ID: 15562128
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
[TBL] [Abstract][Full Text] [Related]
16. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
[TBL] [Abstract][Full Text] [Related]
17. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
Mooney JD; Christie P; Robertson C; Clarke SC
Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
[TBL] [Abstract][Full Text] [Related]
19. [Meningococcal infections. Every case a preventable tragedy].
Bischoff A
MMW Fortschr Med; 2008 Jun; 150(24):17. PubMed ID: 18605054
[No Abstract] [Full Text] [Related]
20. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.
Ramsay ME; Andrews NJ; Trotter CL; Kaczmarski EB; Miller E
BMJ; 2003 Feb; 326(7385):365-6. PubMed ID: 12586669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
